Congress of Clinical Rheumatology Annual Meeting

Healio brings you the highlights from Congress of Clinical Rheumatology annual meeting, and the accompanying North American Young Rheumatology Investigator Forum. Refer back to this page often for the latest news from CCR, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Handheld dynamometry effective for muscle strength assessment in polymyositis

May 5, 2019
DESTIN, Fla. — Handheld dynamometry, a new, inexpensive and quantitative compact device, proved reliable and effective in evaluating muscle…
Meeting News

Future of treatment for Behçet syndrome holds promise

May 4, 2019
DESTIN, Fla. — Behçet's syndrome — which is classified as a vasculitis — is marked by distinct features that differentiate…
Meeting News

Counseling patients with Sjögren’s syndrome critical

May 4, 2019
DESTIN, Fla. — An expert emphasized how important it is to counsel patients with
Meeting News

Patients with both gout, chronic kidney disease undertreated

May 4, 2019
DESTIN, Fla. — Patients with gout in chronic kidney disease are undertreated, and health care providers need to do more to help patients with…
Meeting News

T follicular helper cells linked to active RA development

May 4, 2019
DESTIN, Fla. — T follicular helper cells, which are predominantly located in splenic lymphoid follicles, and their accumulated circulation in…
Meeting News

Cush offers drug 'safety rules to live by' for rheumatologists

May 3, 2019
DESTIN, Fla. — The riskiest thing you can do, when it comes to managing treatments for patients with rheumatic diseases, is to “play it…
Meeting News

Expert cautions: 'No set of criteria can replace clinical judgment'

May 3, 2019
DESTIN, Fla. — In a session here, Ronald F. van Vollenhoven, MD, PhD, of the Amsterdam University Medical Center, discussed the clinical…
Meeting News

Sepsis, pneumonia leading causes of readmission in ANCA-associated vasculitis

May 3, 2019
DESTIN, Fla. — Sepsis and pneumonia are among the leading causes of 30- and 90-day hospital readmission among patients with ANCA-associated…
Meeting News

Prevention remains the ‘holy grail’ for RA, and closer than ever

May 2, 2019
DESTIN, Fla. — Although early detection of
Meeting News

JAK inhibitors, ustekinumab show promise in SLE, more data needed

May 2, 2019
DESTIN, Fla. — JAK inhibitors and ustekinumab have emerged as promising treatments for systemic lupus erythematosus, and more research is…